10x Genomics Raises $55M in Series E
10x Genomics has successfully raised $55M in a Series E at a $500M valuation led by Softbank Vision Fund, Fidelity.
Company Overview
10x Genomics is a Biotech company headquartered in Pleasanton, CA, founded in 2012 with 800+ employees.
Single-cell genomics and spatial biology
Fundraising Details
- Amount Raised: $55M
- Round Type: Series E
- Valuation: $500M
- Date: 2018-01-10
- Investors: Softbank Vision Fund, Fidelity
About 10x Genomics
Single-cell genomics and spatial biology The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Pleasanton, CA
- Founded: 2012
- Team Size: 800+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in 10x Genomics's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. 10x Genomics's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $500M valuation marks an important milestone for 10x Genomics, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, 10x Genomics is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2018-01-10. For more information about 10x Genomics, visit their headquarters at Pleasanton, CA.
